- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 223/16 - Benzazepines; Hydrogenated benzazepines
Patent holdings for IPC class C07D 223/16
Total number of patents in this class: 448
10-year publication summary
|
28
|
33
|
27
|
24
|
34
|
19
|
21
|
21
|
16
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Les Laboratoires Servier | 599 |
45 |
| Arena Pharmaceuticals, Inc. | 381 |
29 |
| Array BioPharma Inc. | 551 |
14 |
| Hoffmann-La Roche Inc. | 3060 |
11 |
| Otsuka Pharmaceutical Co., Ltd. | 1426 |
10 |
| Bolt Biotherapeutics, Inc. | 105 |
10 |
| VentiRx Pharmaceuticals, Inc. | 23 |
9 |
| F. Hoffmann-La Roche AG | 7958 |
8 |
| Cadila Healthcare Limited | 341 |
8 |
| Takeda Pharmaceutical Company Limited | 2961 |
7 |
| Boehringer Ingelheim International GmbH | 4629 |
6 |
| Glaxo Group Limited | 4496 |
5 |
| Board of Regents, The University of Texas System | 5370 |
5 |
| Astellas Pharma Inc. | 1145 |
5 |
| Lek Pharmaceuticals d.d. | 227 |
5 |
| Urquima, S.A. | 12 |
5 |
| Shanghai Zhimeng Biopharma Inc. | 26 |
5 |
| Bristol-myers Squibb Company | 5080 |
4 |
| The Regents of the University of California | 18943 |
4 |
| Janssen Pharmaceutica N.V. | 3839 |
4 |
| Other owners | 249 |